Literature DB >> 23263991

Urinary prothrombin fragment 1+2 in patients with venous thrombosis and myocardial infarction.

J van Es, S Biere-Rafi, M Ahdi, P W Kamphuisen, J C M Meijers, V E A Gerdes.   

Abstract

Patients with venous-thromboembolism (VTE) and myocardial infarction (MI) have elevated prothrombin fragment 1+2 (F1+2) levels. In patients with postoperative VTE, urinary F1+2 (uF1+2) was higher than in individuals without VTE. To explore the relationship between plasma and uF1+2 we performed a pilot study in patients with thrombotic events and healthy controls. In 40 patients with VTE or MI, and 25 age- and sex-matched healthy controls, F1+2 and D-dimer levels were measured in urine and plasma within 48 h after diagnosis. In addition, in all subjects renal function was assessed. Plasma and uF1+2 levels were positively correlated. Compared to controls, patients with VTE had higher levels of both plasma F1+2 (271 vs 160 pmol L(-1), p < 0.05) and uF1+2 levels (38 vs 28 pmol L(-1)), the latter, however, was not statistically significant. Patients with acute MI had similar F1+2 levels as controls in both plasma and urine. Differences in urinary F1+2 levels could not be attributed to differences in concentrations of creatinine or albumin in spot urine samples. Overall, D-dimer and F1+2 levels in urine were extremely low in all groups.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23263991     DOI: 10.1007/s11239-012-0839-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

1.  Identification of a prothrombin derivative in human urine.

Authors:  A Bezeaud; D L Aronson; D Menache; M C Guillin
Journal:  Thromb Res       Date:  1978-09       Impact factor: 3.944

2.  D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.

Authors:  Mojca Bozic; Ales Blinc; Mojca Stegnar
Journal:  Thromb Res       Date:  2002-11-01       Impact factor: 3.944

3.  Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.

Authors:  Lars C Borris; Morten Breindahl; Camilla Ryge; Helle M Sommer; Michael R Lassen
Journal:  Thromb Res       Date:  2007-06-27       Impact factor: 3.944

4.  Assessment of coagulation system activation using spot urine measurements.

Authors:  S E Lind; S Goldshteyn; C P Barry; J R Lindquist; A A Piergies; T Rosen; J R Schneider; D H Shevrin; J A Caprini
Journal:  Blood Coagul Fibrinolysis       Date:  1999-07       Impact factor: 1.276

Review 5.  Prothrombin fragments in cardiovascular disease.

Authors:  J A Páramo
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

6.  Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events.

Authors:  L C Borris; M Breindahl; M R Lassen; A F Pap; F Misselwitz
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

7.  Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.

Authors:  P A Merlini; D Ardissino; K A Bauer; L Oltrona; A Spinola; P Diotallevi; R D Rosenberg; P M Mannucci
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

8.  Development of a radioimmunoassay for quantitating prethrombin 2 in human plasma.

Authors:  E M Conway; H K Lau; K A Bauer; R D Rosenberg
Journal:  J Lab Clin Med       Date:  1987-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.